BRIEF published on 06/03/2025 at 09:05, 6 months 1 day ago CR Energy AG Faces Imminent Insolvency Filing Market Conditions Insolvency Financial Stability CR Energy AG Lender Support
PRESS RELEASE published on 06/03/2025 at 09:00, 6 months 1 day ago Original-Research: CR Energy AG (von NuWays AG): Under Review CR Energy AG, unexpectedly set to file for insolvency, due to market developments and lenders' refusal of further loans. Management seeking equity or debt capital. Analysts suspending rating Lenders Market Developments Equity Capital Insolvency CR Energy AG
BRIEF published on 06/02/2025 at 16:16, 6 months 2 days ago CR Energy AG Faces Imminent Insolvency Proceedings Market Challenges Insolvency Equity Ratio CR Energy AG Subsidiaries Impact
PRESS RELEASE published on 06/02/2025 at 16:11, 6 months 2 days ago Original-Research: CR Energy AG (von First Berlin Equity Research GmbH): Under Review First Berlin Equity Research updates on CR Energy AG expecting insolvency proceedings due to market challenges. Projects of subsidiaries not impacted. Stock rating Under Review Market Challenges First Berlin Equity Research Insolvency Proceedings Stock Rating CR Energy AG
BRIEF published on 12/12/2024 at 09:46, 11 months 23 days ago CR Energy AG Maintains Strong Outlook Amid Sector Challenges Buy Recommendation Financial Outlook CR Energy AG Six-month Report Social Housing Expansion
PRESS RELEASE published on 12/12/2024 at 09:41, 11 months 23 days ago Original-Research: CR Energy AG (von First Berlin Equity Research GmbH): Kaufen First Berlin Equity Research publishes update on CR Energy AG with analyst confirming BUY rating and €12 target price. Focus on operational developments and growth prospects in social housing sector Social Housing First Berlin Equity Research BUY Rating Operational Developments CR Energy AG
BRIEF published on 10/29/2024 at 09:06, 1 year 1 month ago CR Energy AG Shows Strong Performance in H1 Sustainability Investment Funds CR Energy AG Portfolio Companies H1 Performance
PRESS RELEASE published on 10/29/2024 at 09:01, 1 year 1 month ago Original-Research: CR Energy AG (von NuWays AG): Buy CR Energy AG shows positive operating development in H1 with strong portfolio company performance. Expecting significant sales increase by YE '24e. Reiterate BUY with unchanged target price of EUR 12 based on DDM Target Price CR Energy AG Portfolio Companies H1 Report Operating Development
BRIEF published on 08/22/2024 at 09:11, 1 year 3 months ago CR Energy AG Target Price Adjusted after Bonus Shares Issuance Capital Increase Affordable Housing CR Energy AG ELTIF Launch Bonus Shares
PRESS RELEASE published on 08/22/2024 at 09:06, 1 year 3 months ago Original-Research: CR Energy AG (von NuWays AG): BUY CR Energy AG updates with bonus shares issued at a ratio of 1:3, increasing share capital. Focus on sustainable housing solutions for strong performance and new European Long Term Investment Fund launch in H2 Sustainable Housing CR Energy AG Stock Split European Long Term Investment Fund Bonus Shares
Published on 12/05/2025 at 02:35, 2 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
